Yea Sean, I emailed that exact question today arou
Post# of 153822
(Total Views: 561)
Posted On: 05/05/2021 5:49:34 PM
Yea Sean, I emailed that exact question today around 11am but with all the technicalities disrupting the call, it never got answered. Here was the question I asked without my name here but they know who I am
" My question for the webcast to me is a very important one. It's a vital statistic that we all should now. How many patients have been given Leronlimab in the HIV trials that got Covid. The smaller the number the better and its so important for future patients to know this vital statistic as it proves Leronlimab works for HIV patients beyond HIV. Not getting Covid while on Leronlimab is a tremendous accomplishment.
I also would like to know and I feel Cytodyn would be in better shape knowing that with proven results that after being administered Leronlimab for any of our trials to date and especially for the up coming Brazil trials, how many have gone on to get Long Haulers syndrome or PASC. Wouldn't that be a tremendous secondary end point to know and if they are minimal, would surely be something the world needs to know?
Thank you in advance Dr. Pourhassan, Dr. Kelly & Dr. Recknor for all you have done and without all of you at the helm, especially in the very beginning in 2012 with Dr. Pourhassan buying this great molecule from Madden, where would Cytodyn be today. Great job and I'm proud of all of you for be so tenacious in your drive to bring Leronlimab to fruition. Bravo gentleman.
Best to you all and stay safe and well,
XXXXXXX
Now, all of you, don't laugh about my pay grade as I am still working and hope to work til I'm 80, ha ha
" My question for the webcast to me is a very important one. It's a vital statistic that we all should now. How many patients have been given Leronlimab in the HIV trials that got Covid. The smaller the number the better and its so important for future patients to know this vital statistic as it proves Leronlimab works for HIV patients beyond HIV. Not getting Covid while on Leronlimab is a tremendous accomplishment.
I also would like to know and I feel Cytodyn would be in better shape knowing that with proven results that after being administered Leronlimab for any of our trials to date and especially for the up coming Brazil trials, how many have gone on to get Long Haulers syndrome or PASC. Wouldn't that be a tremendous secondary end point to know and if they are minimal, would surely be something the world needs to know?
Thank you in advance Dr. Pourhassan, Dr. Kelly & Dr. Recknor for all you have done and without all of you at the helm, especially in the very beginning in 2012 with Dr. Pourhassan buying this great molecule from Madden, where would Cytodyn be today. Great job and I'm proud of all of you for be so tenacious in your drive to bring Leronlimab to fruition. Bravo gentleman.
Best to you all and stay safe and well,
XXXXXXX
Now, all of you, don't laugh about my pay grade as I am still working and hope to work til I'm 80, ha ha
(4)
(0)